Comment on "Dosing implications for liposomal amphotericin B in pregnancy"
Pharmacotherapy
.
2023 Sep;43(9):991.
doi: 10.1002/phar.2862.
Authors
Wan-Yu Chu
1
2
,
Thomas P C Dorlo
1
Affiliations
1
Department of Pharmacy, Uppsala University, Uppsala, Sweden.
2
Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
PMID:
37701937
DOI:
10.1002/phar.2862
No abstract available
Publication types
Letter
Comment
MeSH terms
Amphotericin B* / administration & dosage
Female
Humans
Pregnancy
Substances
liposomal amphotericin B
Amphotericin B